Skip to content

Effect of neuromuscular blockade reversal agent on BIS (bispectral index) and PSI (patient state index) under sevoflurane anesthesia in children

Effect of neuromuscular blockade reversal agent on BIS (bispectral index) and PSI (patient state index) under sevoflurane anesthesia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006300
Enrollment
94
Registered
2021-06-29
Start date
2021-06-28
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pediatric patients who have American society of anesthesiologist physical status ether class I or II Patients who are planned to undergo elective surgery using sevoflurane anesthesia.

Exclusion criteria

Exclusion criteria: A person who is in the taboo of using sevoflurane - Patients with a history of allergy or hypersensitivity reactions, and malignant hyperthermia. Neuromuscular disease or mental illness Those diagnosed with metabolic diseases Long term opioid use Severe liver, kidney disease People who have contraindications to muscle relaxants - Patients who have allergies to drugs or have a history of hypersensitivity reactions, respiratory disease patients, arrhythmia patients

Design outcomes

Primary

MeasureTime frame
comparison of the magnitude of change in Patient State Index and Bispectral Index

Secondary

MeasureTime frame
Comparison of the magnitude of change in PSI EMG and BIS EMG;correlation of the change in PSI and BIS ;the pattern of change in BIS ;the pattern of change in PSI;the pattern of change in BIS EMG;the pattern of change in PSI EMG;comparison of the magnitude of change in BIS value between high EMG activity(>=35) and no EMG activity(<35) group

Countries

Korea, Republic of

Contacts

Public Contactjeayoun kim

Samsung Medical Center

kimjy0705@naver.com+82-2-3410-6580

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026